Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to $114.5 million.

  • Centessa Pharmaceuticals' Shares Outstanding (Diluted Average) rose 15.41% to $134.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.2 million, marking a year-over-year increase of 15.41%. This contributed to the annual value of $114.5 million for FY2024, which is 19.02% up from last year.
  • As of FY2024, Centessa Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $114.5 million, which was up 19.02% from $96.2 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $114.5 million in FY2024 and a low of $93.4 million during FY2022.
  • Over the past 3 years, Centessa Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $96.2 million (recorded in 2023), while the average stood at $101.4 million.
  • Data for Centessa Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY rose of 19.02% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Centessa Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $93.4 million in 2022, then rose by 2.97% to $96.2 million in 2023, then climbed by 19.02% to $114.5 million in 2024.